Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07362329 · ClinicalTrials.gov registry record · NA

Use of Exercise Snacks to Improve Upper Body Fitness

A NA study, sponsored by New York Institute of Technology.

Active
Registry status
NA
Development phase
50
Enrollment target

NCT07362329: Active NA study, sponsored by New York Institute of Technology.

NCT07362329 is a NA study that is active but no longer recruiting, run by New York Institute of Technology. The registered enrollment target is 50 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07362329, a NA study, is active but no longer recruiting, sponsored by New York Institute of Technology.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target

Study Summary

This study will examine the effects of an upper-body resistance "exercise snack" (ES) protocol on upper-body strength, endurance, and power. Participants will be randomly assigned to one of three groups: a submaximal effort repeated throughout the exercise day ES group, a maximal effort performed once per exercise day ES group, and a control group that continues usual activity (Control: no resistance exercise). Both exercise groups will perform two exercises, push-ups and planks, three days per week. The submaximal repeated effort ES group (SMR\_ES) will perform approximately 33% of the maximal number of push-ups and maintain a plank position for 33% of maximal time, three times per day. The maximal once-per-day effort ES group (MO\_ES) will perform the maximal number of push-ups and maintain a plank position for maximal time, once per day. Therefore, both ES groups (SMR\_ES and MO\_ES) will perform the same weekly volume (repetitions and time) of both exercises across the six-week intervention period. Before and after the six-week intervention period, all participants will undergo testing to assess upper-body performance. Outcome measures will include push-up endurance (maximum repetitions), plank endurance (maximum time), push-up power (assessed using force plates), and maximal push strength (assessed using hand-held dynamometry). Pre- and post-intervention changes in outcomes will be compared among all three groups. If significant changes are identified, additional comparisons will be conducted between the SMR\_ES and Control groups, as well as between the SMR\_ES and MO\_ES groups. The primary aim of this study is to determine whether repeated submaximal efforts performed three times per day, three days per week, increase upper-body endurance, power, and strength compared to a control group performing no resistance exercise. The secondary aim is to determine whether submaximal efforts performed three times per day, three days per week, produce changes in upper

Primary Outcome

Upper-body muscular strength will be assessed using a hand-held dynamometer during a standardized pushing task. Participants will push a barbell upward against an immovable strap connected to a pull dynamometer. Peak force output (Newtons) will be recorded.

Interventions

  • BEHAVIORAL Submaximal Repeated Exercise Snack
  • BEHAVIORAL Maximal One-Time Exercise Snack

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2026-02-01
Est. Completion 2026-04-25
Phase NA
New York Institute of Technology

49 total trials

What the registry record for NCT07362329 still lists

NCT07362329 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).

The record links to 0 conditions, and to 2 interventions - of which Submaximal Repeated Exercise Snack is the first listed.

NCT07362329 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT07362329 about?

NCT07362329 is a clinical study titled "Use of Exercise Snacks to Improve Upper Body Fitness". This study will examine the effects of an upper-body resistance "exercise snack" (ES) protocol on upper-body strength, endurance, and power. Participants will be randomly assigned to one of three groups: a submaximal effort repeated throughout the exercise day ES group, a maximal effort performed on...

What is the current status of trial NCT07362329?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2026-02-01. Estimated completion is 2026-04-25.

What interventions are being tested in trial NCT07362329?

The interventions under investigation include: Submaximal Repeated Exercise Snack (BEHAVIORAL), Maximal One-Time Exercise Snack (BEHAVIORAL).

Who is sponsoring clinical trial NCT07362329?

This trial is sponsored by New York Institute of Technology, which has 49 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT07362329's enrollment target sits among peer trials

50 1279th of 2000 higher than 622 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00200889 · 50 participants · Early Phase 1

    Mapping Auricular Vagus Nerve Circuitry

  • NCT00409435 · 50 participants · Phase 2

    A Study of Pyridostigmine in Postural Tachycardia Syndrome

  • NCT01202305 · 50 participants

    The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies

  • NCT01225913 · 50 participants · Phase 4

    Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07362329, the US trial registry maintained by the National Library of Medicine. NCT07362329 (small enrollment · none site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.